How Johnson & Johnson is looking to lead the way in ablation

“If you want to go fast, go alone. If you want to go forward, go together,” Johnson & Johnson’s Celine Martin (left) said of innovation during a DeviceTalks West 2022 keynote interview with MassDevice executive editor Chris Newmarker (right). [Image by Kara Singleton, WTWH Media]Celine Martin, Johnson & Johnson group chair, cardiovascular & specialty solutions (CSS) group, oversees high-growth areas at the company’s global MedTech business.

Her leadership covers Acclarent, Biosense Webster, Cerenovus and Mentor. Together, those companies bring in more than $5 billion in annual sales with more than 14,000 employees.

Over 25 years at Johnson & Johnson, Martin has looked to improve standards of care for AFib, stroke and minimally invasive surgery. At DeviceTalks West in Santa Clara last week, she spoke in a keynote address about how she’s done it.

On treating AFib at Biosense Webster

Martin said at DeviceTalks that…

Read more
  • 0

Medtronic unveils new neurovascular innovation incubator program

Dan Volz (right) and Derek Crittenden (left) present the Medtronic Co-Lab program at DeviceTalks West in Santa Clara, California.

Medtronic (NYSE:MDT) revealed its plans for an incubation and acceleration platform for innovation in the neurovascular space.

In a presentation yesterday at DeviceTalks West in Santa Clara, California, the company unveiled its plan to bring innovations to market to address strokes. Daniel Volz, president of Medtronic Neurovascular, and Derek Crittenden, Medtronic’s new technology & strategy program manager, presented the news.

“We’re pleased to share with you today the Medtronic neurovascular Co-Lab platform,” Volz said. “This is a community platform designed to transform ideas and technologies into novel global therapies by providing physicians and entrepreneurs with insight with support, and most importantly, making sure innovation has the chance to touch as many people around the world as possibl…

Read more
  • 0

Ablation is the next step for Intuitive’s Ion system

The Ion system integrates with Siemens Healthineers’ Cios Spin mobile imaging system

Intuitive is best known for its da Vinci surgical robotics system, but there is buzz around its Ion system with its fully articulating catheter making its way through the lungs for cancer biopsy.

Watch out for the Ion doing even more down the road.

CEO Gary Guthart announced during Intuitive’s Q3 earnings call yesterday evening that the company has obtained German regulatory approval for a clinical study of Ion ablation technology. “We know that Ion can navigate in deep into the lung. We know that surgeons and interventional pulmonologists want to treat tissue there. They want to be able to engage with it one way or another,” Guthart said during the call, transcribed by The Motley Fool.

During a keynote interview today at DeviceTalks West in Santa Clara, California, Guthart said there could be even further opportunities for the technology down the…

Read more
  • 0

How medical device companies can better protect themselves from lawsuits

Getting hit with lawsuits isn’t an if, but a when for medical device developers and manufacturers. A veteran Greenberg Traurig lawyer shares advice for staying secure.

[Image from Pixabay]

As with pharmaceutical companies and health providers, medtech is emerging from the COVID-19 pandemic with a great deal of goodwill, says Ginger Pigott, a Greenberg Traurig shareholder. Pigott has seen the industry’s improved image helping device companies with juries, mock juries and the litigation process in general.

But don’t bet on the trend lasting.

“I’ve been practicing for 30 years, and it goes in that cycle all the time,” Pigott said in a recent interview with Medical Design & Outsourcing. (Pigott will moderate a panel about building startups to last at DeviceTalks West, Oct. 19-20, 2022 in Santa Clara, California.)

In fact, Pigott suspects the present economic unc…

Read more
  • 0

What’s next for the medical device supply chain?

A host of medical device companies with manufacturing in Puerto Rico found their supply chains impacted by Hurricane Maria in 2017. It was a harbinger of what was to come. [Image is public domain]Recent hurricanes in Florida and Puerto Rico provide yet another reminder that the medical device supply chain remains vulnerable to climate change.

The COVID-19 pandemic presented its challenges. But as our sister Medical Design & Outsourcing site reported last year, expect superstorms, fires, droughts and other extreme events driven by climate change to continue to strain the supply chain.

Problems may even get worse.

Major medtech companies are taking steps to respond to the challenge. For example, Medtronic’s Supply Chain EVP Greg Smith overall has been driving changes with a team that is mostly new to the company. Medtronic has co-located over 100 Medtronic employees with top suppliers and worked directly with commodity and raw material suppliers, CE…

Read more
  • 0

September 2022 Issue: The Medtech Big 100 is bigger than ever

Medtech sales reach a record high as R&D spend and employee counts climb

Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future

Autotransfusion device maker ships units to Ukraine

How IP protection is enabling robotic surgery innovation

Connected device design for the real world: Managing the development process

FDA details plans to expand remote safety assessments for device makers

Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye

The Medtech Big 100 is bigger than ever

The tide has turned.

The Medtech Big 100 — Medical Design & Outsourcing‘s annual revenue ranking of the world’s …

Read more
  • 0

Join us at DeviceTalks West, the World’s Fair of Medtech

Intuitive Surgical CEO Gary Guthart will participate in a keynote interview at DeviceTalks West 2022. [Photo courtesy of Intuitive Surgical]

October’s DeviceTalks West conference is focused on the future.

The best-seller “Devil in the White City” may have darkened the perception of world’s fairs, but these international convocations have long presented visitors with an optimistic and hopeful view of the future, thanks in no small part to new technology. (The next one is scheduled for 2025 in Osaka, Japan, by the way.)

I like to think we’ll be following similar guidelines at the upcoming DeviceTalks West conference, which will be held on Oct. 19-20 at the Santa Clara Convention Center.

This event will bring together executives from Abbott, Boston Scientific, Edwards Lifesciences, Intuitive, Johnson & Johnson, Medtronic, Outset Medical, Penumbra, Shockwave, Zimmer Biomet and many …

Read more
  • 0